Human Insulin Inhalation Powder
Human Insulin Inhalation Powder is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
Clinical Trials (9)
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
A Study for Patients With Type 1 Diabetes Mellitus
A Study for Patients With Type 2 Diabetes Mellitus
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9